Why is "Graft-versus-host disease" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-21 03:14:18
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. GvHD is commonly associated with bone marrow transplants and stem cell transplants.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Matched Sibling Donors Are Still ‘Gold Standard’ in PTCy Allo-HCT Era - targetedonc.com
-
After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse - Medical Xpress
-
What to Know About Graft-Versus-Host Disease (GVHD) | Newswise - Newswise
-
Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host disease - Nature
-
New Regimen Protects Against Cancer Relapse, Graft-Versus-Host Disease After Donor Stem Cell Transplant - Roswell Park Comprehensive Cancer Center
-
From Leukemia Diagnosis to Life After Transplant - Cure Today
-
Safety Analysis of Axatilimab in Patients with Chronic Graft-Versus-Host Disease in an Expanded Access Program - OncLive
-
Case Report: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency - Frontiers
-
Novel drug regimen reduces risks of graft-versus-host disease - fredhutch.org
-
Transformative therapies for sickle cell disease - CMAJ
-
Graft versus Host Disease (GvHD) Treatment Market Size, 2034 - Fortune Business Insights
-
Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host disease - ScienceDirect.com
-
Europe Rejects Graft-vs-Host Disease Therapy - Medscape
-
Experimental Approach to Graft-vs-Host Disease Prophylaxis Offers Alternative to Standard Regimen - The ASCO Post
-
Patient With Bilateral Infracts and Vasculitis With Graft vs Host Disease - Neurology® Journals
-
Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation - Nature
-
New drug regimen prevents both chronic and acute graft-versus-host disease - fredhutch.org
-
Case Report: Successful treatment of steroid-refractory graft-vs.-host disease following bilateral lung transplantation - Frontiers
-
Researchers Identify Strategy for Reducing Risk of Acute Graft-Versus-Host Disease for Many With Blood Cancers - Roswell Park Comprehensive Cancer Center
-
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil - Nature
-
Sanofi’s Rezurock receives positive CHMP opinion for chronic graft-versus-host disease - PMLiVE
-
Renal Involvement in Chronic Graft‐Versus‐Host Disease - Desai - 2025 - European Journal of Haematology - Wiley Online Library
-
Renal Involvement in Chronic Graft‐Versus‐Host Disease - Desai - European Journal of Haematology - Wiley Online Library
-
New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease - News-Medical
-
Graft-versus-Host Disease: Gastrointestinal Tract - BMT infonet.org
-
The Role of Dupilumab in Atopic Dermatitis-Like Graft-Versus-Host Disease - Cureus
-
GVHD in Children: What Dermatologists Need to Know - Medscape
-
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease - cancernetwork.com
-
Staying Safe and Active with Graft Versus Host Disease - BMT infonet.org
-
New Treatments to Prevent or Treat Graft-versus-Host Disease - BMT infonet.org
-
Biochemical markers and emerging therapies for intestinal manifestation of graft-versus-host disease - Frontiers
-
Sanofi comes up against a graft-versus-host disease rock | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
-
Demand for Graft Versus Host Disease Treatment in USA | Global Market Analysis Report - 2036 - Future Market Insights
-
Regulatory T cell therapy for Graft-versus-Host Disease - Nature
-
Graft-versus-Host Disease: What to Do When it Affects your Eyes - BMT infonet.org
-
9 Foods to Avoid or Limit if You Have Chronic Graft-Versus-Host Disease (GVHD) - Everyday Health
-
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey - Nature
-
Cynata reaches crucial milestone as Phase 2 trial moves toward results - PharmaDispatch
-
13 Best Foods for Chronic Graft-Versus-Host Disease (GVHD), According to Dietitians - Everyday Health
-
Depend on Biomarkers, Not Symptoms, for Diagnosis, Early Treatment of GVHD, Experts Argue - managedhealthcareexecutive.com
-
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease - NEJM
-
Graft-versus-host disease: teaching old drugs new tricks at less cost - Frontiers
-
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis - NEJM
-
Validation of Minnesota acute graft-versus-host disease Risk Score - Haematologica
-
A Case of Fetal-Induced Graft-versus-Host Disease - NEJM
-
PET assessment of acute gastrointestinal graft versus host disease | Bone Marrow Transplantation - Nature
-
Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era - Nature
-
Graft vs. host disease: 6 things to know about this stem cell transplant side effect - UT MD Anderson
-
Graft-versus-host disease - Nature
-
The ocular graft-versus-host disease: the path from current knowledge to future managements | Eye - Nature
-
Ruxolitinib plus steroids for acute graft versus host disease: a multicenter, randomized, phase 3 trial - Nature
-
Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice - Nature
-
The development of graft-versus-host disease prophylaxis - Haematologica
-
Understanding and treatment of cutaneous graft-versus-host-disease | Bone Marrow Transplantation - Nature
-
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation - Nature
-
The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients | Scientific Reports - Nature
-
Oral Chronic Graft-Versus-Host Disease - Frontiers
-
Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy - NEJM
-
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease - Leukemia - Nature
-
Construction of a digital twin of chronic graft vs. host disease patients with standard of care - Nature
-
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape - Nature
-
More Evidence that Ruxolitinib Benefits Some Patients with Graft-Versus-Host Disease - National Cancer Institute (.gov)
-
Life with graft-vs.-host disease: When the transplant is just the beginning - fredhutch.org
-
Potential of TCR sequencing in graft-versus-host disease - Nature
-
Introduction to Graft-versus-Host Disease (GVHD) - BMT infonet.org
-
Outcome predictions for patients with graft-versus-host disease - fredhutch.org
-
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease - NEJM
-
Antibody treatment prevents graft versus host disease in advanced preclinical tests - Penn Medicine
-
FDA Approves Belumosudil for Chronic GVHD - National Cancer Institute (.gov)
-
Mystery solved: How graft-vs.-host disease starts in the gut - fredhutch.org
-
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease - Nature
-
Data-driven grading of acute graft-versus-host disease - Nature
-
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management - Nature
-
Graft Versus Host Disease Market Statistics and Forecast - 2031 - Allied Market Research
-
Ask the Graft-versus-Host Disease Experts - BMT infonet.org
-
Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France - Nature
-
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using 18F-FDG PET - Journal of Nuclear Medicine
-
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease - NEJM
-
Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience - Nature
-
Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives - Frontiers
-
Consensus reached on initial treatment of acute graft-versus-host disease in patients who receive bone marrow transplant; nothing definitive yet for secondary treatment - Mayo Clinic
-
Factors Linked to Fatigue With Chronic Graft-versus-Host Disease - Oncology Nurse Advisor
-
Acute Graft-versus-Host DiseaseRadioGraphics - RSNA Journals
-
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality - Nature
-
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease - Nature
-
Dynamic forecasting of severe acute graft-versus-host disease after transplantation - Nature
-
Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program - Nature
-
Pitt Study Reframes Understanding of Graft-Versus-Host Disease - UPMC
-
Overview of Graft-Versus-Host Disease - OncLive
-
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib - Nature
-
Your Mouth and Chronic Graft-versus-Host Disease - BMT infonet.org
-
Novel therapies for graft versus host disease with a focus on cell therapies - Frontiers
-
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC | Bone Marrow Transplantation - Nature
-
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation | Bone Marrow Transplantation - Nature
-
An enterococcal phage-derived enzyme suppresses graft-versus-host disease - Nature
-
Study Sets New Standard for Graft-Versus-Host Disease Prevention After Stem Cell Transplant - Johns Hopkins Medicine
-
Graft-versus-Host Disease: Advances in Prevention and Treatment - BMT infonet.org
-
Protective Conditioning for Acute Graft-versus-Host Disease - NEJM
-
What’s new in combatting chronic graft-vs.-host disease - fredhutch.org
-
Transfusion-Associated Graft-Versus-Host Disease in Adults - Cureus
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.